CI
MYGN icon

Cowen Inc’s Myriad Genetics MYGN Stock Holding History

Cowen Inc’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,000
Closed -$34K – 378
2015
Q2 		$34K Buy
+10,000
New +$340K ﹤0.01% 443
2014
Q1 		– Sell
-20,000
Closed -$420K – 222
2013
Q4 		$420K Buy
+20,000
New +$506K 0.07% 172
2013
Q3 		– Sell
-5,000
Closed -$134K – 260
2013
Q2 		$134K Buy
+5,000
New +$145K 0.01% 224

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cowen Inc's MYGN Position: Q3 2015 in Review

Cowen Inc sold out of Myriad Genetics (MYGN) in Q3 2015, closing a stake of 2,000 shares.

Cowen Inc first reported a position in MYGN in Q4 2013 and held it in 2 quarters. The position peaked at $63K in Q4 2013. 234 funds tracked by Wall St. Rank hold MYGN as of Q3 2015.

  • Cowen Inc reported no remaining Myriad Genetics position as of Q3 2015 after selling out during the quarter.
  • Cowen Inc sold 2,000 Myriad Genetics shares in Q3 2015.
  • Cowen Inc first reported a position in Myriad Genetics in Q4 2013 and held it in 2 quarters.
  • Cowen Inc's Myriad Genetics position peaked at $63K in Q4 2013.
  • 234 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.